BING NAN,BRILEY LINDA PERRY,BUDDE LAURA R,COX CHARLES J,SPRAGGS COLIN F
申请号：
ZA201201110
公开号：
ZA201201110B
申请日:
2012.02.15
申请国别(地区):
ZA
年份:
2012
代理人:
摘要：
Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB； rs12153855 and/or rs17207923.
